Cleveland Clinic Heart, Vascular & Thoracic Institute reaches healthcare leaders in China meeting the needs of healthcare leaders with virtualized solutions.
Looking for a benchmark for your heart failure or electrophysiology program? Check out some of our key volume and outcome statistics from these subspecialties in this dynamic infographic.
A new JACC statement makes the case for earlier referral of patients with advanced heart failure. Our experts review the recommendations and the rationale behind them.
A large case series shows that catheter ablation of refractory ventricular arrhythmia in patients with cardiogenic shock can allow for liberation from mechanical support in most cases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Sleep apnea is associated with heart failure, atrial fibrillation, stroke, coronary artery disease and cardiovascular mortality. CPAP treatment may reduce the risk of cardiac events, indicate some data.
SGLT2 inhibitors for heart failure with preserved ejection fraction will be the No. 10 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Promising observational data suggest it’s time for a prospective study of this therapy in heart failure patients with reduced ejection fraction and low cardiac output who are receiving IV therapies.
Encouraging findings from this sham-controlled study of the Carillon device for transvenous mitral annuloplasty in functional mitral regurgitation pique interest in the large ongoing CARILLON trial.
The data is showing some positive results, and the nursing team continues to examine if group education for heart failure patients might improve outcomes. There are many factors.
Looking for benchmarks for heart failure or arrhythmia care? Check out some of our latest volume and outcome data in these areas via this dynamic infographic.